Kiora Pharmaceuticals (KPRX) vs Phio Pharmaceuticals (PHIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kiora Pharmaceuticals (KPRX) has outperformed Phio Pharmaceuticals (PHIO) over the past year, losing 7.3% versus a loss of 57.5%. Over five years, PHIO leads with a -99.4% price change compared with -99.6% for KPRX. Phio Pharmaceuticals is the larger company by market cap ($11.6 million vs $11.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KPRX | PHIO |
|---|---|---|
| Share price | $2.53 | $0.9995 |
| Market cap | $11.19M | $11.61M |
| 1-day change | +1.20% | +0.51% |
| YTD return | +28.43% | -4.81% |
| 1-year return | -7.33% | -57.47% |
| 5-year return | -99.64% | -99.45% |
| EPS (TTM) | $-2.46 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.91 | $4.19 |
| 52-week low | $1.77 | $0.813 |
| Distance from 52-week high | -13.06% | -76.15% |
| Average volume | 17.06K | 591.85K |
| Shares outstanding | 4.42M | 11.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KPRX has outperformed PHIO by 50.1 percentage points over the past year.
KPRX vs PHIO FAQ
Which is bigger, Kiora Pharmaceuticals or Phio Pharmaceuticals?
Phio Pharmaceuticals (PHIO) is larger, with a market capitalization of $11.61M compared with $11.19M for Kiora Pharmaceuticals (KPRX).
Which stock has performed better over the past year, KPRX or PHIO?
KPRX returned -7.33% over the past 12 months, compared with -57.47% for PHIO (price return, excluding dividends). Past performance does not predict future results.
Are Kiora Pharmaceuticals and Phio Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.